首页|再生障碍性贫血异基因造血干细胞移植后继发性植入功能不良的危险因素

再生障碍性贫血异基因造血干细胞移植后继发性植入功能不良的危险因素

扫码查看
目的 探讨再生障碍性贫血(AA)患者异基因造血干细胞移植(Allo-HSCT)后发生继发性植入功能不良(sPGF)的危险因素.方法 收集2016年1月至2021年6月在郑州大学第一附属医院造血干细胞移植中心接受Allo-HSCT的后存活超过28 d的213例AA患者的临床资料,排除非首次移植、植入失败及移植排斥的患者,共185例患者被纳入研究,将纳入患者分为sPGF组和植入功能良好(GGF)组,采用x2检验和二元logistic回归对可能影响sPGF的因素进行分析.结果 纳入研究的185例行Allo-HSCT的AA患者中,共有29例发生sPGF.危险因素分析显示两组间+12 d中性粒细胞未植入、Ⅱ~Ⅳ度急性移植物抗宿主病(aGVHD)病史、移植后EB病毒(EBV)血症病史是sPGF发生的危险因素(OR=3.747,P=0.023;OR=5.545,P=0.003;OR=3.314,P=0.026).生存分析显示 sPGF组3a生存率低于 GGF组(P<0.001).结论 AA移植后发生sPGF预后差,对+12d中性粒细胞未植入、Ⅱ~Ⅳ度aGVHD病史、移植后EBV血症病史高危患者应加强监测、早期诊断并干预,从而提高AA患者移植疗效.
Risk Factors for Secondary Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation in Aplastic Anemia
Objective To investigate the risk factors of secondary poor graft function(sPGF)after allogeneic hematopoietic stem cell transplantation(Allo-HSCT)for aplastic anemia(AA).Methods Clinical data of 213 patients who survived more than 28 days after Allo-HSCT at the Hematopoietic Stem Cell Transplantation Center of the First Affiliated Hospital of Zhengzhou University from January 2016 to June 2021,excluding graft failure,a total of 185 patients were included in the study and divided into the sPGF group and the good graft function(GGF)group.The x2 test and logistic regression were used to analyze the factors that might affect the sPGF.Results Among the 185 AA patients who underwent Allo-HSCT,29 developed sPGF.Statistical analysis showed+12 days without neutrophil engraftment,history of grades Ⅱ-Ⅳ acute graft-versa-host disease(aGVHD)and Epstein-Barr virus(EBV)infection were significant risk factors for sPGF(OR=3.747,P=0.023;OR=5.545,P=0.003;OR=3.314,P=0.026).Survival analysis showed that the 3 years survival rate was significantly lower in the sPGF group than in the GGF group(P<0.001).Conclusion Patients with sPGF after AA transplantation have a poor prognosis.For patients with+12 days without neutrophil engraftment,history of grades Ⅱ-Ⅳ aGVHD and EBV infection,Early identification and intervention should be performed to improve the efficacy of transplantation.

anemiaaplasticallogeneic hematopoietic stem cell transplantationsecondary poor graft functionrisk factor

范金鹏、李丽、边志磊、张素平、高思雨、林湘涵、李岩、万鼎铭

展开 >

郑州大学第一附属医院血液科,河南郑州 450052

贫血 再生障碍性 异基因造血干细胞移植 继发性植入功能不良 危险因素

国家自然科学基金面上项目

82170211

2024

河南医学研究
河南省医学科学院

河南医学研究

影响因子:0.979
ISSN:1004-437X
年,卷(期):2024.33(13)
  • 4